Subset of Aggressive Prostate Tumors Contain BRCA2 Mutations

Apr 14, 2016

|

NEW YORK (GenomeWeb) – A new study in the American Journal of Human Genetics suggests a subset of aggressive prostate tumors are marked by alterations affecting both copies of BRCA2, a gene best known for its role in breast and ovarian cancer risk.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

French Funding Agency Head Resigns

The president of France's National Research Agency has resigned, according to Nature News.

Right to Try Versus Clinical Trials

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

This Week in PNAS

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

'Lifestyle Zone'

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

Featured White Papers

Yield NGS-grade DNA/RNA from 10 or 20 μL of dried blood preserved on a non-invasive collection device

Generating Mouse Models with CRISPR/Cas9

A Method to Streamline and Miniaturize Nextera Library Preparation for Illumina Next-Gen Sequencing Using the Labcyte Echo 525 Liquid Handler

Successful Miniaturization of Molecular Biology Reaction Volumes: Using Mosquito HTS for Gateway Cloning, PCR Amplification and Nextera Library Generation

Sep

07

Featured Webinar

Improved Library Prep Workflows for Small RNA NGS in Serum and Plasma

This webinar will address improvements in the library prep workflow for small RNA sequencing in serum and plasma.

Sep

21

Featured Webinar

Processing Challenging Tumor Samples via Automated Tissue Dissection and Extraction-Free Library Prep

This webinar will demonstrate a new approach that combines precise FFPE tumor isolation with extraction-free DNA/RNA library preparation to minimize material losses and reduce the amount of tissue input required for NGS analysis.

Main menu